[1] W.J. Heerink, G.H. de Bock, G.J. de Jonge, H.J. Groen, R. Vliegenthart, M. Oudkerk, Complication rates of CT-guided transthoracic lung biopsy: meta-analysis, Eur Radiol, 27 (2017) 138-148.
[2] D.M. Minot, E.A. Gilman, M.C. Aubry, J.S. Voss, S.G. Van Epps, D.J. Tuve, A.P. Sciallis, M.R. Henry, D.R. Salomao, P. Lee, S.K. Carlson, A.C. Clayton, An investigation into false-negative transthoracic fine needle aspiration and core biopsy specimens, Diagn Cytopathol, 42 (2014) 1063-1068.
[3] Y.J. Hong, J. Hur, H.J. Lee, J.E. Nam, Y.J. Kim, H.S. Kim, H.Y. Kim, S.K. Kim, J. Chang, J.H. Kim, K.Y. Chung, B.W. Choi, K.O. Choe, Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer, J Thorac Oncol, 6 (2011) 1330-1335.
[4] S.B. Solomon, M.F. Zakowski, W. Pao, R.H. Thornton, M. Ladanyi, M.G. Kris, V.W. Rusch, N.A. Rizvi, Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis, AJR Am J Roentgenol, 194 (2010) 266-269.
[5] H. Saji, H. Nakamura, T. Tsuchida, M. Tsuboi, N. Kawate, C. Konaka, H. Kato, The incidence and the risk of pneumothorax and chest tube placement after percutaneous CT-guided lung biopsy: the angle of the needle trajectory is a novel predictor, Chest, 121 (2002) 1521-1526.
[6] J.P. Ko, J.O. Shepard, E.A. Drucker, S.L. Aquino, A. Sharma, B. Sabloff, E. Halpern, T.C. McLoud, Factors influencing pneumothorax rate at lung biopsy: are dwell time and angle of pleural puncture contributing factors?, Radiology, 218 (2001) 491-496.
[7] A. Oikonomou, F.R. Matzinger, J.M. Seely, C.J. Dennie, P.J. Macleod, Ultrathin needle (25 G) aspiration lung biopsy: diagnostic accuracy and complication rates, Eur Radiol, 14 (2004) 375-382.
[8] M.Z. Nikolic, L.S. Lok, K. Mattishent, S. Barth, B. Yung, N.M. Cummings, D. Wade, Y. Vali, K. Chong, A. Wilkinson, T. Mikolasch, S. Brij, H.S. Jenkins, A.V. Kamath, M. Pasteur, T.G. Hopkins, J. Wason, S.J. Marciniak, Noninterventional statistical comparison of BTS and CHEST guidelines for size and severity in primary pneumothorax, Eur Respir J, 45 (2015) 1731-1734.
[9] R. Pellegrino, G. Viegi, V. Brusasco, R.O. Crapo, F. Burgos, R. Casaburi, A. Coates, C.P. van der Grinten, P. Gustafsson, J. Hankinson, R. Jensen, D.C. Johnson, N. MacIntyre, R. McKay, M.R. Miller, D. Navajas, O.F. Pedersen, J. Wanger, Interpretative strategies for lung function tests, Eur Respir J, 26 (2005) 948-968.
[10] D.M.G. Halpin, G.J. Criner, A. Papi, D. Singh, A. Anzueto, F.J. Martinez, A.A. Agusti, C.F. Vogelmeier, Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease, Am J Respir Crit Care Med, 203 (2021) 24-36.
[11] G.L. Ruppel, P.L. Enright, Pulmonary function testing, Respir Care, 57 (2012) 165-175.
[12] P. Vitulo, R. Dore, I. Cerveri, C. Tinelli, P. Cremaschi, The role of functional respiratory tests in predicting pneumothorax during lung needle biopsy, Chest, 109 (1996) 612-615.
[13] F. Garcia-Rio, J.M. Pino, J. Casadevall, L. Gomez, J.M. Atienza, S. Diaz-Lobato, J. Villamor, Use of spirometry to predict risk of pneumothorax in CT-guided needle biopsy of the lung, J Comput Assist Tomogr, 20 (1996) 20-23.
[14] E.A. Kazerooni, F.T. Lim, A. Mikhail, F.J. Martinez, Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung, Radiology, 198 (1996) 371-375.
[15] C.M. Heyer, S. Reichelt, S.A. Peters, J.W. Walther, K.M. Muller, V. Nicolas, Computed tomography-navigated transthoracic core biopsy of pulmonary lesions: which factors affect diagnostic yield and complication rates?, Acad Radiol, 15 (2008) 1017-1026.
[16] S. Otto, B. Mensel, N. Friedrich, S. Schafer, C. Mahlke, W. von Bernstorff, K. Bock, N. Hosten, J.P. Kuhn, Predictors of technical success and rate of complications of image-guided percutaneous transthoracic lung needle biopsy of pulmonary tumors, PLoS One, 10 (2015) e0124947.
[17] S. Taleb, H. Jalaeian, N. Frank, J. Golzarian, D. D'Souza, Is a Routine Chest X-ray Necessary in Every Patient After Percutaneous CT-Guided Lung Biopsy? A Retrospective Review of 278 Cases, Cardiovasc Intervent Radiol, 40 (2017) 1415-1420.
[18] Y.C. Cheung, J.W. Chang, J.J. Hsieh, G. Lin, Y.H. Tsai, Adequacy and complications of computed tomography-guided core needle biopsy on non-small cell lung cancers for epidermal growth factor receptor mutations demonstration: 18-gauge or 20-gauge biopsy needle, Lung Cancer, 67 (2010) 166-169.
[19] H. Li, P.M. Boiselle, J.O. Shepard, B. Trotman-Dickenson, T.C. McLoud, Diagnostic accuracy and safety of CT-guided percutaneous needle aspiration biopsy of the lung: comparison of small and large pulmonary nodules, AJR Am J Roentgenol, 167 (1996) 105-109.
[20] K.M. Yeow, L.C. See, K.W. Lui, M.C. Lin, T.C. Tsao, K.F. Ng, H.P. Liu, Risk factors for pneumothorax and bleeding after CT-guided percutaneous coaxial cutting needle biopsy of lung lesions, J Vasc Interv Radiol, 12 (2001) 1305-1312.
[21] J.E. McDonough, R. Yuan, M. Suzuki, N. Seyednejad, W.M. Elliott, P.G. Sanchez, A.C. Wright, W.B. Gefter, L. Litzky, H.O. Coxson, P.D. Pare, D.D. Sin, R.A. Pierce, J.C. Woods, A.M. McWilliams, J.R. Mayo, S.C. Lam, J.D. Cooper, J.C. Hogg, Small-airway obstruction and emphysema in chronic obstructive pulmonary disease, The New England journal of medicine, 365 (2011) 1567-1575.
[22] K. Day, K. Ostridge, J. Conway, D. Cellura, A. Watson, C.M. Spalluto, K.J. Staples, B. Thompson, T. Wilkinson, Interrelationships Among Small Airways Dysfunction, Neutrophilic Inflammation, and Exacerbation Frequency in COPD, Chest, (2020).